RxDoctor Payments Data

Julie Connor

Adult Health · Huntsville, ALNPI 1346619962

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novo Nordisk at 26.7% of the total. Reporting peaked in 2021 at $1,338 and has fallen 77.3% since, to $303 in 2024.

$3,134in general payments, 2019–2025

Across 127 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$837
  • AbbVie$690
  • AstraZeneca$384
  • GSK$224
  • Merck$151
  • Lilly USA, LLC$138
  • plus $710 from 14 others

What the payments were for

  • Food & beverage$3,134100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,134 in reported general payments places this provider in the 80th percentile of 308 adult health providers in Alabama.

See all adult health providers in Alabama

Other adult health in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →